Literature DB >> 32657138

hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis.

Fengjiao Han1, Chaoqin Zhong1,2, Wei Li1, Ruiqing Wang1, Chen Zhang1, Xinyu Yang1, Chunyan Ji1, Daoxin Ma1.   

Abstract

Aim: Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear. Therefore, we aimed to define novel circRNAs involved the development and progression of AML. Materials & methods: We used circRNAs microarray to determine the differential expression profile. Quantitative reverse transcription PCR analyzed the expression of hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947 in vitro and in vivo. A dual-luciferase and mimics/inhibitor were to determine the target gene relationship.
Results: hsa_circ_0001947 functions as a tumor inhibitor to suppress AML cell proliferation through hsa-miR-329-5p/CREBRF axis.
Conclusion: hsa_circ_0001947 may be as a novel potential biomarker for the treatment of AML.

Entities:  

Keywords:  AML; CREBRF; biomarker; circRNAs; hsa-miR-329-5p; hsa_circ_0001947; therapy

Year:  2020        PMID: 32657138     DOI: 10.2217/epi-2019-0352

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  8 in total

Review 1.  Roles of circRNAs in hematological malignancies.

Authors:  Fahua Deng; Chengsi Zhang; Tingting Lu; Ezhong Joshua Liao; Hai Huang; Sixi Wei
Journal:  Biomark Res       Date:  2022-07-15

Review 2.  The functions and clinical significance of circRNAs in hematological malignancies.

Authors:  Xiangxiang Zhou; Linquan Zhan; Kai Huang; Xin Wang
Journal:  J Hematol Oncol       Date:  2020-10-17       Impact factor: 17.388

3.  Circ_0001947 promotes cell proliferation, invasion, migration and inflammation and inhibits apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes through miR-671-5p/STAT3 axis.

Authors:  Yang Yang; Shudian Lin; Zhou Yang; Yanyan Huang; Feng Zhan
Journal:  J Orthop Surg Res       Date:  2022-01-29       Impact factor: 2.359

Review 4.  From circRNAs to fusion circRNAs in hematological malignancies.

Authors:  Loelia Babin; Elissa Andraos; Steffen Fuchs; Stéphane Pyronnet; Erika Brunet; Fabienne Meggetto
Journal:  JCI Insight       Date:  2021-11-08

5.  Serum hsa_circ_0079480 is a novel prognostic marker for acute myeloid leukemia.

Authors:  Liang Guo; Ru Kou; Yanping Song; Guang Li; Xueyou Jia; Zhenzhen Li; Yunjie Zhang
Journal:  J Clin Lab Anal       Date:  2022-03-17       Impact factor: 2.352

Review 6.  Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment.

Authors:  Francesca Liccardo; Alessia Iaiza; Martyna Śniegocka; Silvia Masciarelli; Francesco Fazi
Journal:  Noncoding RNA       Date:  2022-07-01

7.  The Down-Regulation of Circ_0059707 in Acute Myeloid Leukemia Promotes Cell Growth and Inhibits Apoptosis by Regulating miR-1287-5p.

Authors:  Jichun Ma; Xiangmei Wen; Zijun Xu; Peihui Xia; Ye Jin; Jiang Lin; Jun Qian
Journal:  Curr Oncol       Date:  2022-09-18       Impact factor: 3.109

8.  CircRNA CircEHBP1 Regulates the Maturation of MiR-129 to Increase the Chemoresistance of Cancer Cells to Adriamycin in Acute Myeloid Leukaemia.

Authors:  Hong Li; Kehong Bi; Saran Feng; Yan Wang; Chuansheng Zhu
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.